Published in:
01-11-2016 | Commentary
Should preimplantation genetic screening (PGS) be implemented to routine IVF practice?
Authors:
Raoul Orvieto, Norbert Gleicher
Published in:
Journal of Assisted Reproduction and Genetics
|
Issue 11/2016
Login to get access
Excerpt
As compared to day 3 blastomere (spp) biopsy followed by fluorescence in situ hybridization (FISH), PGS 1.0 [
1], the utilization of trophectoderm biopsy (days 5–6 embryos) combined with comprehensive chromosome screening (CCS) tests for embryonic aneuploidy, PGS 2.0, has been suggested to improve in vitro fertilization (IVF) outcome [
2], though not without criticisms [
3,
4]. Here, we draw attention to several underlying factors that will influence decisions to employ PGS 2.0 in routine clinical practice. …